Oral formulations

Details for Australian Patent Application No. 2011100879 (hide)

Owner Novartis AG

Inventors Comfort, Ann; Hunt, Irene

Agent Davies Collison Cave

Pub. Number AU-A-2011100879

Filing date 14 July 2011

Opi date 18 August 2011

International Classifications

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 47/02 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Inorganic compounds

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

28 July 2011 Innovation Patent Application Filed

18 August 2011 Innovation Patent Open to Public Inspection

  Published as AU-A-2011100879

18 August 2011 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011100880-A window winder and a chain

2011100878-Oral formulations